HLA B Intermediate Resolution
Use
HLA B antigens may be correlated with certain disease states or other clinical conditions. Indicate in clinical information which antigen(s) is of interest. Also used for screening of transplant candidates and potential donors, transfusion of specifically compatible blood products, among others.
Special Instructions
Not provided.
Limitations
This test was developed, and its performance characteristics determined, by LabCorp. It has not been cleared or approved by the US Food and Drug Administration (FDA).
Methodology
NGS
Biomarkers
LOINC Codes
- 13299-3 - HLA-B
- 49549-9 - Ref lab test method
- 13299-3 - HLA-B
Result Turnaround Time
3-7 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
7 mL whole blood
Minimum Volume
3 mL whole blood
Container
Lavender‑top (EDTA) tube
Storage Instructions
Maintain specimen at room temperature; protect from extreme heat or cold. Do not freeze.
Causes for Rejection
Hemolyzed specimen; clotted specimen; wrong specimen container
Other tests from different labs that may be relevant